Browse drugs

… for Gem/NabP. Recorded grade ≥3 toxicities appeared lower with NALIRIFOX, although cross-regimen safety comparisons were limited by retr…

…eft nephrectomy and lymph node dissection, followed by adjuvant capecitabine plus oxaliplatin (CAPEOX) chemotherapy. Six months later, she d…

… during treatment with PD-1 inhibitors. Eight patients received pembrolizumab (six as monotherapy and two in combination with carboplatin plu…

…tinum salts (carboplatin, oxaliplatin, cisplatin), and taxanes (paclitaxel, docetaxel).Methods This single-centre, retrospective study was…

…oadjuvant FOLFIRINOX (folinic acid, 5-fluorouracil, irinotecan, oxaliplatin) chemotherapy for borderline resectable pancreatic adenocarcino…

… junction cancer and (3) support the potential incorporation of megestrol acetate into standard antiemetic medications.Ethics and dissemination T…

…systemic therapy with fluorouracil, leucovorin, oxaliplatin and trastuzumab. This resulted in rapid clinical improvement, normalisation of …

… regimen comprising 5-fluorouracil, leucovorin, oxaliplatin and docetaxel, for locally advanced gastro-oesophageal junction adenocarcinom…

…gical therapy (21%), and other (9%). Most implicated drugs were nivolumab, ipilimumab, carboplatin, paclitaxel, oxaliplatin, and pembroli…

…and sarcoma (0.9%). The most frequently desensitised drugs were paclitaxel (45.4%), oxaliplatin (24.5%), carboplatin (14.1%), docetaxel (9…

…amre+apa), CAPOX alone, and camrelizumab plus CAPOX followed by camrelizumab (camre+CAPOX followed by camre) as initial treatment for gastri…

…n 85 mg/m² every 3 weeks), lenvatinib (8 mg/day from Day 5) and Adebrelimab (1200 mg on Day 3, every 3 weeks) for 2–4 cycles. Surgery eligi…